中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Discovery of 2,4-quinazolinedione derivatives as LC3B recruiters in the facilitation of protein complex degradations

文献类型:期刊论文

作者Zeng, Yanping7,8; Xiao, Jian4,7; Shi, Li6; Li, Yangsha4,7; Xu, Yuanxin5; Zhou, Jiayun2; Dong, Xiao4,7; Hou, Haiyang4,7; Zhong, Chao2; Cheng, Gang1
刊名EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
出版日期2025-04-05
卷号287页码:10
关键词LC3B CDK9 Degradation Protein complex
ISSN号0223-5234
DOI10.1016/j.ejmech.2025.117293
英文摘要Targeted protein degradation through autophagosome-tethering compounds (ATTECs) that bypasses the ubiquitination process has garnered increasing attention. LC3B, a key protein in autophagosome formation, recruits substrates into the autophagy-lysosome system for degradation. In this study, we systematically optimized 2,4quinazolinedione derivatives as LC3B-recruiting fragments, utilizing the CDK9 indicator. By attaching the designed LC3B-recruiting fragment to CDK9 inhibitor SNS-032 through a linker, the resulting bifunctional ATTEC molecule simultaneously degraded CDK9 and its associated Cyclin T1. Two-dimensional NMR experiments confirmed the direct interaction between the novel LC3B-recruiting fragments and LC3B. Mechanistic studies elucidated that degradation occurred via an LC3B-dependent autophagy-lysosomal pathway. Additionally, the general applicability of leveraging LC3B-recruiting fragments linked to inhibitors for the targeted degradation of protein complexes was validated with PRC2 and CDK2/4/6 along with their respective Cyclins. This work provides a series of novel LC3B-recruiting fragments that enrich the ATTEC toolbox and can be applied to the degradation of diverse intracellular disease-causing proteins.
WOS关键词ADVANCED BREAST-CANCER ; CELL-CYCLE ; INHIBITION ; ADAPTATION ; PRC2 ; EZH1 ; CDK2
资助项目Shanghai Institute of Materia Medica, Chinese Academy of Sciences[SIMM0220232002] ; National Natural Science Foundation of China[22477126] ; National Natural Science Foundation of China[32171220]
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:001425128500001
出版者ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
源URL[http://119.78.100.183/handle/2S10ELR8/316278]  
专题新药研究国家重点实验室
通讯作者Zhang, Naixia; Fang, Yanfen; Hu, Youhong
作者单位1.Zhejiang Chinese Med Univ, Sch Pharmaceut Sci, Hangzhou 311402, Peoples R China
2.Fudan Univ, Sch Life Sci, Jiangwan Campus,2005 Songhu Rd, Shanghai 200433, Peoples R China
3.Bohai Rim Adv Res Inst Drug Discovery, Shandong Lab Yantai Drug Discovery, Yantai 264117, Shandong, Peoples R China
4.Univ Chinese Acad Sci, 19 Yuquan Rd, Beijing 110039, Peoples R China
5.Nanjing Univ Chinese Med, Sch Chinese Mat Med, 138 Xianlin Rd, Nanjing 210046, Peoples R China
6.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Chem Biol, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China
7.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China
8.Hangzhou Inst Adv Study, Sch Pharmaceut Sci & Technol, 1 Xiangshanzhi Rd, Hangzhou 310024, Peoples R China
推荐引用方式
GB/T 7714
Zeng, Yanping,Xiao, Jian,Shi, Li,et al. Discovery of 2,4-quinazolinedione derivatives as LC3B recruiters in the facilitation of protein complex degradations[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2025,287:10.
APA Zeng, Yanping.,Xiao, Jian.,Shi, Li.,Li, Yangsha.,Xu, Yuanxin.,...&Hu, Youhong.(2025).Discovery of 2,4-quinazolinedione derivatives as LC3B recruiters in the facilitation of protein complex degradations.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,287,10.
MLA Zeng, Yanping,et al."Discovery of 2,4-quinazolinedione derivatives as LC3B recruiters in the facilitation of protein complex degradations".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 287(2025):10.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。